Nanomaterial-based drug delivery carriers for cancer therapy

This brief summarizes different types of organic and inorganic nanomaterials for drug delivery in cancer therapy. It highlights that precisely designed nanomaterials will be the next-generation therapeutic agents for cancer treatment.

Saved in:
Bibliographic Details
Main Authors Feng, Tao (Author), Zhao, Yanli (Author)
Format Electronic eBook
LanguageEnglish
Published Abingdon, Oxon ; New York : Routledge, Taylor and Francis Group, 2017.
Singapore : Springer, 2017.
SeriesSpringerBriefs in applied sciences and technology. Nanotheranostics.
Subjects
Antineoplastic agents.
Drug carriers (Pharmacy)
elektronické knihy
electronic books
Online AccessPlný text

Cover

MARC

LEADER 00000cam a2200000Mi 4500
001 99702
003 CZ-ZlUTB
005 20201229193743.0
006 m o d
007 cr |||||||||||
008 161223t20172017si a ob 000 0 eng d
040 |a IDEBK  |b eng  |e rda  |e pn  |c IDEBK  |d YDX  |d GW5XE  |d N$T  |d EBLCP  |d N$T  |d AZU  |d UAB  |d OCLCF  |d COO  |d UPM  |d IOG  |d ESU  |d JBG  |d IAD  |d ICW  |d ICN  |d OTZ  |d OCLCQ  |d IDEBK  |d VT2  |d IDB  |d U3W  |d MERUC  |d CAUOI  |d EZ9  |d AU@  |d OCLCQ  |d WYU  |d AUD  |d OCLCQ  |d ERF  |d UKBTH  |d LEATE  |d OCLCQ 
020 |a 9789811032998  |q (electronic bk.) 
020 |z 9789811032974 
024 7 |a 10.1007/978-981-10-3299-8  |2 doi 
035 |a (OCoLC)967861663  |z (OCoLC)965904239  |z (OCoLC)966195430  |z (OCoLC)974649782  |z (OCoLC)1005810014  |z (OCoLC)1012054001  |z (OCoLC)1048174920  |z (OCoLC)1058385355  |z (OCoLC)1066426156  |z (OCoLC)1086451549  |z (OCoLC)1112600067  |z (OCoLC)1113050216  |z (OCoLC)1113436413  |z (OCoLC)1117176925  |z (OCoLC)1122848123 
100 1 |a Feng, Tao,  |e author. 
245 1 0 |a Nanomaterial-based drug delivery carriers for cancer therapy /  |c Tao Feng, Yanli Zhao. 
264 1 |a Abingdon, Oxon ;  |a New York :  |b Routledge, Taylor and Francis Group,  |c 2017. 
264 1 |a Singapore :  |b Springer,  |c 2017. 
264 4 |c ©2017 
300 |a 1 online resource (62 pages) :  |b illustrations (some color) 
336 |a text  |b txt  |2 rdacontent 
337 |a počítač  |b c  |2 rdamedia 
338 |a online zdroj  |b cr  |2 rdacarrier 
490 1 |a SpringerBriefs in Applied Sciences and Technology : Nanotheranostics,  |x 2191-5318 
504 |a Includes bibliographical references. 
505 0 |a Acknowledgements; Contents; About the Authors; 1 Current Status and Characteristics of Cancer; 1.1 Abnormal Metabolism; 1.2 Abnormal Vasculature; 1.3 Resistance to Anti-proliferative Growth Factors (GFs); 1.4 Unlimited Replicative Potential; 1.5 Immune System Activation and Inflammation; 1.6 Interstitial Pressure; References; 2 Clinical Anticancer Drugs for Cancer Treatment; 2.1 Antimetabolites; 2.2 Antimitotic Agents; 2.3 Alkylating Agents; 2.4 Antitumor Antibiotics; 2.5 Tyrosine Kinase Inhibitors (TKI); 2.6 Cyclin Dependent Kinase (CDK) Inhibitors. 
505 8 |a 2.7 Poly(ADP-Ribose) Polymerase (PARP) Inhibitors2.8 Histone Deacetyltransferase Inhibitors (HDACi); 2.9 Mitogen-Activated Protein Kinase (MAPK) Kinase (MEK) Inhibitors; 2.10 Serine/Threonine-Protein Kinase B-Raf Inhibitors; 2.11 Mammalian Target of Rapamycin (MTOR) Inhibitors; 2.12 Phosphoinositide 3-Kinase (PI3K) Inhibitors; 2.13 Ribonucleotide Reductase (RNR) Inhibitors; 2.14 DNA Methyltransferase Inhibitors; 2.15 Retinoids; 2.16 Monoclonal Antibodies (MAbs); 2.17 Combination Therapy; References; 3 Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy; 3.1 Introduction. 
505 8 |a 3.2 Organic Nanomaterials3.2.1 FDA-Approved Liposomes; 3.2.2 Polymer-Based Nanoparticles; 3.2.3 Supramolecular Nanosystems; 3.2.4 Others; 3.3 Inorganic Nanomaterials; 3.3.1 Quantum Dots; 3.3.2 Gold Nanomaterials; 3.3.2.1 Gold Nanoparticles; 3.3.2.2 Gold Nanorods; 3.3.3 Mesoporous Silica Nanoparticles; 3.3.4 Carbon Nanomaterials; 3.3.4.1 Carbon Nanotubes; 3.3.4.2 Graphene; 3.3.4.3 Carbon Dots; 3.3.5 Upconversion Nanoparticles; 3.3.6 Two-Dimensional Nanomaterials; 3.3.7 Others; 3.4 Organic-Inorganic Hybrid Nanomaterials; References; Conclusions. 
506 |a Plný text je dostupný pouze z IP adres počítačů Univerzity Tomáše Bati ve Zlíně nebo vzdáleným přístupem pro zaměstnance a studenty 
520 |a This brief summarizes different types of organic and inorganic nanomaterials for drug delivery in cancer therapy. It highlights that precisely designed nanomaterials will be the next-generation therapeutic agents for cancer treatment. 
590 |a SpringerLink  |b Springer Complete eBooks 
650 0 |a Antineoplastic agents. 
650 0 |a Drug carriers (Pharmacy) 
655 7 |a elektronické knihy  |7 fd186907  |2 czenas 
655 9 |a electronic books  |2 eczenas 
700 1 |a Zhao, Yanli,  |e author. 
776 0 8 |i Print version:  |a Feng, Tao.  |t Nanomaterial-based drug delivery carriers for cancer therapy.  |d Singapore : Springer, 2017  |z 9811032971  |z 9789811032974  |w (OCoLC)962007637 
830 0 |a SpringerBriefs in applied sciences and technology.  |p Nanotheranostics. 
856 4 0 |u https://proxy.k.utb.cz/login?url=https://link.springer.com/10.1007/978-981-10-3299-8  |y Plný text 
992 |c NTK-SpringerENG 
999 |c 99702  |d 99702 

Similar Items